Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (11)

« Back to Publications

What are patients’ and healthcare professionals’ views on managing penicillin allergy? A qualitative evidence synthesis

Kildonaviciute K. et al, (2026), Jac Antimicrobial Resistance, 8

An Economic Evaluation of Direct Oral Penicillin Challenge for De-Labelling Low Risk Patients With a Penicillin Allergy Label

Bestwick R. et al, (2025), Clinical and Experimental Allergy, 55, 378 - 390

Direct oral penicillin challenge in secondary care with low-risk patients: the SPACE mixed-methods study with cost-effectiveness analysis

Krishna MT. et al, (2025), Health and Social Care Delivery Research, 13

Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)

Chorafa E. et al, (2025), Journal of Pediatric Hematology Oncology

Antifungal Drug Usage in European Neonatal Units: A Multicenter Weekly Point Prevalence Study

Chorafa E. et al, (2024), The Pediatric infectious disease journal, 43, 1047 - 1048

Factors influencing implementation and adoption of direct oral penicillin challenge for allergy delabelling: a qualitative evaluation

Jani YH. et al, (2024), BMJ Open Quality, 13

Our experience as pharmacists in ‘SPACE’

Ng BY. et al, (2024), Pharmaceutical Journal, 312

A multicentre observational study to investigate feasibility of a direct oral penicillin challenge in de-labelling ‘low risk’ patients with penicillin allergy by non-allergy healthcare professionals (SPACE study): Implications for healthcare systems

Krishna MT. et al, (2024), Journal of Infection, 88

Cefazolin as second line treatment for invasive Methicillin-Susceptible Staphylococcus aureus infection in a UK cohort of patients

Young BC. et al, (2021), Journal of Infection, 82, e25 - e27

Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: Should public campaigns change focus?

Micallef C. et al, (2017), Journal of Antimicrobial Chemotherapy, 72, 311 - 314

Impact of a candidaemia care bundle on patient care at a large teaching hospital in England

Gouliouris T. et al, (2016), Journal of Infection, 72, 501 - 503